IP Library Granted Patent US 8,852,672
Granted Patent B2
US 8,852,672 · App. 13/648,837 · Granted Oct 7, 2014

Implant surface with increased hydrophilicity

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,852,672
App. No.
13/648,837
Granted
Oct 7, 2014
Kind
B2
Abstract

A method of increasing the hydrophilicity of an implant to be implanted into living bone. The method comprises the act of depositing non-toxic salt residuals on the surface of the implant by exposing the surface to a solution including the non-toxic salts. The method further comprises the act of drying the implant.

Claims (22)

1. A method of forming an implant to be implanted into living bone, the method comprising the acts of:

roughening at least a portion of the implant surface to form a roughened surface; and

increasing the hydrophilicity of the roughened surface by depositing non-toxic sodium lactate salt residuals on the roughened surface by exposing the roughened surface to a solution including the non-toxic sodium lactate salt.

2. The method of claim 1 , wherein the implant is made of titanium or titanium alloy and the act of roughening the implant surface comprises:

removing a native oxide layer from the implant surface; and

acid etching the resulting surface.

3. The method of claim 2 , wherein the implant is a dental implant including a head portion having a non-rotational feature, a lowermost end opposing the head portion, and a threaded bottom portion for engaging bone between the head portion and the lowermost end, the native oxide being removed from a threaded bottom portion of the implant.

4. The method of claim 1 , wherein the act of roughening the implant surface creates irregularities having peak-to-valley heights not greater than about 20 microns.

5. The method of claim 1 , wherein the solution is selected from the group consisting of physiological saline solution and lactated Ringer's solution.

6. The method of claim 1 , further comprising, prior to the act of depositing non-toxic sodium lactate salt residuals, depositing discrete nanoparticles on the roughened surface by exposing the roughened surface to a solution including the nanoparticles, the nanoparticles comprising a material having a property that promotes osseointegration.

7. The method of claim 6 , wherein the nanoparticles are hydroxyapatite nanocrystals and the solution including the nanoparticles is 2-methoxyethanol solvent.

8. The method of claim 7 , wherein the hydroxyapatite nanocrystals are on the order of about 20 nanometers to about 100 nanometers.

9. The method of claim 1 , wherein a contact angle formed by a deionized water droplet on the surface of the implant ranges from about 5° to about 65°.

10. The method of claim 1 , further comprising sterilizing the implant using gamma sterilization.

11. The method of claim 1 , further comprising, prior to the act of roughening, grit blasting at least a portion of the implant surface with a grit blast media.

12. The method of claim 11 , wherein the grit blast media is a resorbable grit blast media.

13. The method of claim 12 , wherein the resorbable grit blast media includes calcium phosphate.

14. The method of claim 13 , further comprising removing residual grit blast media by exposing the grit blasted portion of the implant surface to nitric acid.

15. A method of forming an implant to be implanted into living bone, the method comprising the acts of:

roughening at least a portion of the implant surface to form a roughened surface; and

increasing the hydrophilicity of the roughened surface by depositing discrete non-toxic salt residuals on the roughened surface by exposing the roughened surface to a solution including the non-toxic salt, wherein the non-toxic salt includes sodium lactate.

16. The method of claim 15 , wherein the solution is selected from the group consisting of physiological saline solution and lactated Ringer's solution.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Oct 20, 2025
From: JPMORGAN CHASE BANK, N.A.
To: BIOMET 3I, LLC; ZIMMER DENTAL INC.
Reel/Frame 073142/0312 →
SECURITY INTEREST Recorded Oct 20, 2025
From: BIOMET 3I, LLC; ZIMMER DENTAL INC.; IMPLANT CONCIERGE, LLC
To: GOLUB CAPITAL LLC, AS COLLATERAL AGENT
Reel/Frame 073142/0384 →
SECURITY INTEREST Recorded Mar 2, 2022
From: BIOMET 3I, LLC; EBI, LLC; ZIMMER BIOMET SPINE, INC.; ZIMMER DENTAL INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 059293/0213 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 8, 2013
From: CHARLTON, JACQUELINE K.; MAYFIELD, ROBERT L.; TOWSE, ROSS W.
To: BIOMET 3I, LLC
Reel/Frame 030168/0420 →